Athira pharma to participate in two upcoming investor conferences

Bothell, wash., march 21, 2022 (globe newswire) -- athira pharma, inc. (nasdaq: atha), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that members of athira pharma's senior management team will participate in the following upcoming investor conferences.
ATHA Ratings Summary
ATHA Quant Ranking